微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 85.21% | 2.32% | -0.01% | 7/159 | 48.56% | 首药控股 | 96.95% | 行业排名> |
| 2026-06-30 | 85.22% | 3.21% | -0.04% | 13/159 | 48.66% | 海创药业 | 97.34% | 行业排名> |
| 2026-03-31 | 85.26% | 4.76% | 2.58% | 14/159 | 50.28% | 海创药业 | 99.82% | 行业排名> |
| 2025-12-31 | 83.12% | -9.97% | -0.2% | 17/159 | 50.37% | 海创药业 | 98.62% | 行业排名> |
| 2025-09-30 | 83.29% | -11.94% | 0.86% | 17/159 | -2.12% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 82.57% | -12.71% | 1.46% | 15/159 | 15.05% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 81.39% | -13.94% | -11.84% | 15/159 | 31.79% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 92.32% | -1.22% | -2.39% | 7/159 | 51.61% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 94.58% | 1.45% | -0.01% | 4/159 | 22.43% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 94.59% | 1.63% | 0.02% | 5/159 | 32.96% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 94.57% | 2.44% | 1.19% | 5/159 | 51.47% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 93.45% | 0.69% | 0.24% | 5/159 | 51.31% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 93.23% | 0.34% | 0.16% | 4/159 | 32.31% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 93.08% | 0.84% | 0.83% | 4/159 | 38.22% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 92.31% | -1.01% | -0.53% | 5/159 | 52.66% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 92.81% | 0.07% | -0.11% | 5/159 | 53.51% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 92.91% | 2% | 0.66% | 4/159 | 5.67% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 92.3% | 2% | -1.02% | 4/159 | 20.91% | 迈威生物 | 99.44% | 行业排名> |
| 2022-03-31 | 93.25% | 2% | 0.54% | 3/159 | 54.06% | 迈威生物 | 98.57% | 行业排名> |
| 2021-12-31 | 92.75% | 2% | 2% | 7/159 | 54.9% | 首药控股 | 99.93% | 行业排名> |